Functional interactions of the entorhinal cortex: An18F-FDG PET study on normal aging and Alzheimer's disease

Journal of Nuclear Medicine

Volumn 45, Issue 3, 2004, Pages 382-392

  Mosconi, Lisa ^a   Pupi, Alberto ^a   De Cristofaro, M Teresa R ^a   Fayyaz, Mozghan ^a   Sorbi, Sandro ^a   Herholz, Karl ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

18F FDG; Aging; Alzheimer's disease; Connectivity; Entorhinal cortex; Functional interactions; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; GLUCOSE METABOLISM; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BRAIN; BRAIN MAPPING; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; METABOLISM; METHODOLOGY; MIDDLE AGED; NERVE TRACT; SCINTISCANNING; STATISTICS;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; ENTORHINAL CORTEX; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEURAL PATHWAYS; RADIOPHARMACEUTICALS; STATISTICS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2342525914     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002;17:302-316.
2. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82:239-259.
3. Delacourte A, David JP, Sergeant N, et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 1999;52:1158-1165.
4. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996;16:4491-4500.
5. Insausti R, Amaral DG, Cowan WM. The entorhinal cortex of the monkey. II. Cortical afferents. J Comp Neurol. 1987;264:356-395.
6. Meguro K, Blaizot X, Kondoh Y, Le Mestric C, Baron JC, Chavoix C. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET: implications for Alzheimer's disease. Brain. 1999;122:1519-1531.
7. Hayashi T, Fukuyama H, Katsumi Y, et al. Cerebral glucose metabolism in unilateral entorhinal cortex-lesioned rats: an animal PET study. Neuroreport. 1999;10:2113-2118.
8. 18F]fluoro-deoxy-D-glucose/positron- emission tomography (FDG/PET). Proc Natl Acad Sci USA. 2001;98:10966-10971.
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
10. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638-643.
11. Minoshima S, Koeppe RA, Frey KA, Kuhl DE. Anatomical standardization: linear scaling and non linear warping of functional brain images. J Nucl Med. 1994;35:1528-1537.
12. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System - An Approach to Cerebral Imaging. New York, NY: Thieme Medical; 1988.
13. Lancaster JL, Woldorff MG, Parsons LM, et al. Automated Talairach Atlas labels for functional brain mapping. Human Brain Mapp. 2000;10:120-131.
14. Horwitz B, Duara R, Rapoport SI. Intercorrelations of glucose rates between brain regions: application to healthy males in a reduced state of sensory input. J Cereb Blood Flow Metab. 1984;4:484-499.
15. Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Functional connectivity: the principal component analysis of large (PET) data sets. J Cerebr Blood Flow Metab. 1993;13:5-14.
16. Friston KJ, Buechel C, Fink GR, Morris J, Rolls E, Dolan RJ. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage. 1997;6:218-229.
17. Brett M, Anton J-L, Valabregue R, Poline J-B. Region of interest analysis using an SPM toolbox [abstract]. Proceedings of the 8th International Conference on Functional Mapping of the Human Brain. Sendai, Japan. 2002;16:497.
18. Bobinski M, de Leon MJ, Convit A, et al. MRI of entorhinal cortex in mild Alzheimer's disease. Lancet. 1999;353:38-40.
19. Prohovnik I, Hakansson K, Risberg J. Observations on the functional significance or regional cerebral blood flow in "resting" normal subjects. Neuropsychologia. 1980;18:203-217.
20. Van Hoesen GW, Pandya DN. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. III. Efferent connections. Brain Res. 1975;95:39-59.
21. Suzuki WA, Amaral DG. Perirhinal and parahippocampal cortices of the macaque monkey: cortical afferents. J Comp Neurol. 1994;350:497-533.
22. Millien I, Blaizot X, Giffard C, et al. Brain glucose hypometabolism after perirhinal lesions in baboons: implications for Alzheimer disease and aging. J Cereb Blood Flow Metab. 2002;22:1248-1261.
23. Martin AJ, Friston KJ, Colebatch JG, Frackowiak RS. Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab. 1991;11:684-689.
24. Petit-Tabouè MC, Landeau B, Desson JF, Desgranges B, Baron JC. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage. 1998;7:176-184.
25. 18F]fluorodeoxyglucose. J Comput Assist Tomogr. 1983;7:590-598.
26. Jagust WJ, Reed BR, Seab JP, Budinger TF. Alzheimer's disease: age at onset and single-photon emission computed tomographic patterns of regional cerebral blood flow. Arch Neurol. 1990;47:628-633.
27. Desgranges B, Baron JC, de la Sayette V, et al. The neural substrates of memory systems impairment in Alzheimer's disease: a PET study of resting brain glucose utilization. Brain. 1998;121:611-631.
28. Thompson PM, Moussai J, Zohoori S, et al. Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex. 1998;8:492-509.
29. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci. 2003;6:309-315.
30. De Lacoste MC, White CL 3rd. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging. 1993;14:1-16.
31. Mielke R, Schroder R, Fink GR, Kessler J, Herholz K, Heiss WD. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol (Berl). 1996;91:174-179.
32. Ibanez V, Pietrini P, Alexander GE, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology. 1998;50:1585-1593.
33. Mielke R, Kessler J, Szelies B, Herholz K, Wienhard K, Heiss WD. Normal and pathological aging: findings of positron-emission-tomography. J Neural Transm. 1998;105:821-837.
34. Desgranges B, Baron JC, Giffard B, et al. The neural basis of intrusions in free recall and cued recall: a PET study in Alzheimer's disease. Neuroimage. 2002;17:1658-1664.
35. Grady CL, McIntosh AR, Craik FI. Age-related differences in the functional connectivity of the hippocampus during memory encoding. Hippocampus. 2003;13:572-586.
36. Grady CL, Furey ML, Pietrini P, Horwitz B, Rapoport SI. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain. 2001;124:739-756.